LEC#37 Anti Diabetic Drugs (Insulin)

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 20

ANTI DIABETIC DRUGS

BY
DR.SAMREEN ALI
Associate Professor (Pharmacology)
OVERVIEW:
 The pancreas is both an endocrine gland that produces
the peptide hormone insulin, glucagon, and somatostatin
and an exocrine gland that produces digestive enzymes.

 The peptide hormones are secreted from cells located in


the islets of Langerhans (β cells produce insulin, α cells
produce glucagon, and δ cells produce somatostatin).

 These hormones play an important role in regulating the


metabolic activities of the body, particularly the
homeostasis of blood glucose.
CONT….
Hyperinsulinemia can cause severe
hypoglycemia.

 A relative or absolute lack of insulin, such as in


diabetes mellitus, can cause serious
hyperglycemia.

If this condition is left untreated, retinopathy,


nephropathy, neuropathy, and cardiovascular
complications may result.
DIABETES MELLITUS

The incidence of diabetes is growing rapidly


worldwide.

Diabetes is not a single disease. Rather, it is a


heterogeneous group of syndromes characterized
by an elevation of blood glucose caused by a
absolute or relative deficiency of insulin.
CONT…
The American Diabetes Association (ADA)
recognizes four clinical classifications of diabetes:
 type 1 diabetes (formerly, insulin dependent
diabetes mellitus),
type 2 diabetes (formerly, non-insulin dependent
diabetes mellitus),
gestational diabetes, and
diabetes due to other causes (for example, due to
medications).
TYPE 1 DIABETES
 Type 1 diabetes most commonly afflicts individuals in puberty
or early Adulthood.

 The disease is characterized by an absolute deficiency of


insulin caused by massive Loss of β-cell function is usually
ascribed to autoimmune-mediated processes directed against
the β cell, and it may be triggered by an invasion of viruses or
the action of chemical toxins.

 As a result of the destruction of these cells, the pancreas fails


to respond to glucose, and the type 1 diabetic shows classic
symptoms of insulin deficiency (polydipsia, polyphagia,
polyuria, and weight loss).
TREATMENT:
 A person with type 1 diabetes must rely on exogenous
(injected) insulin to control hyperglycemia,to avoid to avoid
long term complications like diabetic ketoacidosis, and
maintain acceptable levels of glycosylated hemoglobin
(HbA1c).

 The rate of formation of HbA1c is proportional to the


average blood glucose concentration over the previous 3
months.

 Therefore, HbA1c provides a measure of how well


treatment has normalized blood glucose in diabetic patients.
TYPE 2 DIABETES
Most diabetic patients have type 2 disease. Type 2
diabetes is influenced by genetic factors, aging,
obesity, and peripheral insulin resistance.

The metabolic alterations observed are milder than


those described for type 1 .In contrast to patients
with type 1, those with type 2 diabetes are often
obese.

This resistance to insulin is considered to be a


major cause of this type of diabetes.
TREATMENT:
The goal in treating type 2 diabetes is to maintain
blood glucose concentrations within normal limits
and to prevent the development of long-term
complications of the disease.

 Weight reduction, exercise, and dietary


modification decrease insulin resistance and
correct the hyperglycemia of type 2 diabetes in
some patients.
Insulin
Classification Rapid acting
Insulin lispro

Insulin aspart

Insulin glulisin

Short acting
Regular

Intermediate acting
Neutral protamine hagadron

Long acting
Insulin glargine

Insulin detemir
INSULIN ADMINISTRATION:
 Because insulin is a polypeptide, it is degraded in the
gastrointestinal tract if taken orally. Therefore, it is generally
administered by subcutaneous injection.

 In a hyperglycemic emergency, regular insulin is injected


intravenously (IV).

 Continuous subcutaneous insulin infusion (insulin pump) has


become popular, because it does not require multiple daily
injections.

.
RAPID-ACTING INSULIN:
 Insulin lispro, insulin aspart, and insulin glulisine are rapid
actiing insulin Because of their rapid onset and short
duration of action.

 This results in more rapid absorption after subcutaneous


injection.
CONT…
They are administered to mimic the prandial
(mealtime) release of insulin, and they are
usually not used alone but with a longer-
acting insulin to ensure proper glucose
control.
SHORT-ACTING INSULIN
 Regular insulin is a short-acting.
Onset = within 30 min
Duration of action =6-8hours

It is usually given subcutaneously (or IV in


emergencies).
INTERMEDIATE-ACTING INSULIN
Onset 30 min-2 hrs
Duration 4-12 hrs
Neutral protamine Hagedorn (NPH) insulin .
Another name for this preparation is insulin
isophane.
It is useful in treating all forms of diabetes except
diabetic ketoacidosis and emergency hyperglycemia.
LONG-ACTING INSULIN
 1. Insulin glargine: It is slower in onset than NPH
insulin and has a flat, prolonged hypoglycemic effect
with no peak.
 Like the other insulins, it must be given
subcutaneously.

 2. Insulin detemir: Insulin detemir has a fatty-acid


sidechain. This addition enhances association to
albumin.

 Slow dissociation from albumin results in long-acting


properties similar to those of insulin glargine.
ADVERSE EFFECTS
OF INSULIN
Hypoglycemia
Lipodystrophy
hypersensitivity

You might also like